ONCT · Oncternal Therapeutics
Acquired Company
GTx, Inc. completed its merger with Private Oncternal on June 7, 2019, after which the combined company adopted the name Oncternal Therapeutics, Inc. and commenced trading under the ticker ONCT.
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of cancer therapies for cancers with critical unmet medical needs. The company is headquartered in San Diego, California.
12230 EL CAMINO REAL, SAN DIEGO, CA, UNITED STATES, 92130, San Diego, CA, 92130, USA
BIOTECHNOLOGY
HEALTHCARE
Market Cap
1.559M
52 Wk Range
$0.00 - $0.00
Previous Close
$0.53
Open
$0.53
Volume
N/A
Day Range
$0.53 - $0.53
Enterprise Value
N/A
Cash
13.08M
Avg Qtr Burn
-6.953M
Insider Ownership
9.23%
Institutional Own.
12.07%
Qtr Updated
Sep 30th 2024